NHS Cancer Waiting Times Deteriorate: Nuffield Trust Analysis Reveals Decline
UKPulse Health Desk
NHS cancer waiting times have worsened significantly over the past decade, with fewer patients receiving timely diagnoses and treatment. A new report by the Nuffield Trust highlights a concerning trend away from national targets.
- Only 61.5% of patients started cancer treatment within two months of an urgent GP referral in January 2024, well below the 85% target.
- The 62-day waiting time target has not been met nationally since December 2015.
- The 28-day faster diagnosis target, introduced in 2021, has also never been met, with only 71.3% of patients receiving a diagnosis or ruling out cancer within this timeframe in January 2024.
- The Nuffield Trust suggests that increased demand for cancer services, workforce shortages, and the impact of the pandemic are contributing factors to the decline.
- Longer waiting times can lead to poorer outcomes for patients and increased anxiety.
New data from the Nuffield Trust paints a worrying picture of the NHS's ability to diagnose and treat cancer patients quickly. Over the past decade, key targets have been consistently missed, putting patient outcomes at risk.
As of January 2024, only 61.5% of patients referred urgently for suspected cancer had started their treatment within two months – a far cry from the national target of 85%. The NHS has struggled to meet this crucial 62-day waiting time target since December 2015. What's more, the newer 28-day faster diagnosis target, introduced in 2021, remains elusive, with only 71.3% of patients receiving a diagnosis or having cancer ruled out within 28 days that same month.
The Nuffield Trust points to a complex mix of factors contributing to these disappointing results: rising demand for cancer services, persistent workforce shortages, and lingering pandemic-related backlogs. While some areas showed improvement during the immediate aftermath of the COVID-19 pandemic, the overall trend remains one of decline.
Longer waiting times carry severe consequences for patients – they can allow cancers to progress, making treatment more complex and less effective. The wait itself is a source of immense stress and anxiety for those affected and their loved ones.
The Nuffield Trust's analysis serves as a stark reminder of the need for sustained effort to address these systemic issues and ensure timely access to life-saving cancer care.
Why this matters: This matters because delayed cancer diagnosis and treatment can lead to poorer health outcomes and increased patient anxiety. The consistent missing of targets indicates a significant strain on the NHS's ability to provide timely cancer care.
What this means for you: What this means for you: If you are concerned about cancer symptoms, it is crucial to contact your GP promptly. While the NHS is facing challenges, early diagnosis remains vital. For medical advice, always consult your GP or call NHS 111.